Showing results (501-510 of 609) with videos related to

Sort By:
Pageof 61
Chest|January 29, 2020
Noninvasive Prognostic Biomarkers for Left-Sided Heart Failure as Predictors of Survival in Pulmonary Arterial HypertensionCatherine E Simpson, Rachel L Damico, Paul M Hassoun, et al.
Applied Clinical Informatics|August 22, 2025
A Mixed-Method Case Study to Evaluate Adoption of Clinical Decision Support for Cancer Symptom ManagementJennifer L Ridgeway, Deirdre R Pachman, Lila J Finney Rutten, et al.
Pulmonary Circulation|May 18, 2019
United States Pulmonary Hypertension Scientific Registry (USPHSR): rationale, design, and clinical implicationsC Gregory Elliott, Eric D Austin, David Badesch, et al.
Pulmonary Circulation|May 4, 2022
Hepatoma-derived growth factor is associated with pulmonary vascular remodeling and PAH disease severity and survivalJun Yang, Anjira S Ambade, Melanie Nies, et al.
The AAPS Journal|June 27, 2025
Procedural Variation May Contribute to 6-Minute Walk Distance Variability in Real-World Pediatric Pulmonary Arterial Hypertension StudyCynthia Kleppinger, Dunbar Ivy, Norman Stockbridge, et al.
The Journal of Pediatrics|November 3, 2024
Actigraphy Study Endpoints to Reduce Sample Size and Facilitate Drug Development for Pediatric Pulmonary Arterial HypertensionHaihao Sun, Norman Stockbridge, D Dunbar Ivy, et al.
Applied Clinical Informatics|June 18, 2025
Using Electronic Health Records to Classify Cancer Site and MetastasisKurt Kroenke, Kathryn J Ruddy, Deirdre R Pachman, et al.
Pulmonary Circulation|September 7, 2023
Low-affinity insulin-like growth factor binding protein 7 and its association with pulmonary arterial hypertension severity and survivalGuillermo Torres, Andrew C Lancaster, Jun Yang, et al.
Pulmonary Circulation|January 17, 2017
Shared gene expression patterns in mesenchymal progenitors derived from lung and epidermis in pulmonary arterial hypertension: identifying key pathways in pulmonary vascular diseaseChrista Gaskill, Shennea Marriott, Sidd Pratap, et al.
Cancer Research|June 17, 2022
Leveraging Therapy-Specific Polygenic Risk Scores to Predict Restrictive Lung Defects in Childhood Cancer SurvivorsCindy Im, Yan Yuan, Eric D Austin, et al.
Pageof 61